Follow
Maria Guillamot
Maria Guillamot
Postdoctoral Fellow NYU Medical Center
Verified email at nyumc.org - Homepage
Title
Cited by
Cited by
Year
Restoration of TET2 function blocks aberrant self-renewal and leukemia progression
L Cimmino, I Dolgalev, Y Wang, A Yoshimi, GH Martin, J Wang, V Ng, ...
Cell 170 (6), 1079-1095. e20, 2017
4802017
The bone marrow microenvironment at single-cell resolution
AN Tikhonova, I Dolgalev, H Hu, KK Sivaraj, E Hoxha, ...
Nature 569 (7755), 222-228, 2019
4792019
Killing cells by targeting mitosis
E Manchado, M Guillamot, M Malumbres
Cell Death & Differentiation 19 (3), 369-377, 2012
2372012
Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α, δ phosphatase
E Manchado, M Guillamot, G de Cárcer, M Eguren, M Trickey, ...
Cancer cell 18 (6), 641-654, 2010
2112010
MED12 regulates HSC-specific enhancers independently of mediator kinase activity to control hematopoiesis
B Aranda-Orgilles, R Saldaña-Meyer, E Wang, E Trompouki, A Fassl, ...
Cell stem cell 19 (6), 784-799, 2016
942016
The impact of DNA methylation in hematopoietic malignancies
M Guillamot, L Cimmino, I Aifantis
Trends in cancer 2 (2), 70-83, 2016
672016
Regulation of stem cell function by protein ubiquitylation
A Strikoudis, M Guillamot, I Aifantis
EMBO reports 15 (4), 365-382, 2014
472014
Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription
M Guillamot, E Manchado, M Chiesa, G Gómez-López, DG Pisano, ...
Scientific reports 1 (1), 1-7, 2011
462011
The CUL4-DDB1 ubiquitin ligase complex controls adult and embryonic stem cell differentiation and homeostasis
J Gao, SM Buckley, L Cimmino, M Guillamot, A Strikoudis, Y Cang, ...
Elife 4, e07539, 2015
332015
The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation
M Guillamot, D Ouazia, I Dolgalev, ST Yeung, N Kourtis, Y Dai, K Corrigan, ...
Nature immunology 20 (9), 1196-1207, 2019
272019
The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway
M Chiesa, M Guillamot, MJ Bueno, M Malumbres
Cell Cycle 10 (10), 1607-1617, 2011
182011
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
T Muto, M Guillamot, J Yeung, J Fang, J Bennett, B Nadorp, A Lasry, ...
Cell Stem Cell 29 (2), 298-314. e9, 2022
62022
Splicing the innate immune signalling in leukaemia
M Guillamot, I Aifantis
Nature cell biology 21 (5), 536-537, 2019
22019
The impact of inflammation-induced tumor plasticity during myeloid transformation
A Yeaton, G Cayanan, S Loghavi, I Dolgalev, EM Leddin, CE Loo, ...
Cancer Discovery, 2022
2022
Clinical and Pathologic features of North American/Caribbean Adult T-cell leukemia/lymphoma (ATLL), the Brooklyn, NY experience
Y Sun, M Guillamot, I Dolgalev, I Aifantis, CA Axiotis
Medical Research Archives 9 (10), 2021
2021
Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity
T Muto, M Guillamot, J Fang, LZ Redondo, K Choi, Y Gong, CS Walker, ...
Blood 134, 727, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–16